REGISTERED COMPANY NUMBER: 07016271 (England and Wales)
REGISTERED CHARITY NUMBER.. 1133643
Report of the Trustee$ gnd
Unaudited Flnancial Statements
for the Year Ended 31 M4r¢h 2024
ror
PHARMACO FOUNDATION LTD
Brindleys Limited
2 Wheeleys Road
Edgbaslon
Birniingham
West Midlands
B15 2LD

PHARMACO FOUNDATION LTD
Contents of the Financial Statements
for the Year Ended 31 Mar¢h 2024
Page
Report of the Tru$tee5
Independent Examiner's Report
Statement of Flnancigl Actlvi¢ies
Statement of Fin9n¢ial Positlon
5 to 6
Notes ¢0 the Finan¢l41 Ststements
7 to 12
Detailed St&tement of Fin&n¢S9l Activities
13

PHARMACO FOUNDATION LTD
Report of the Trustees
for the Year Ended 31 March 2024
The trustees who are also directors of the charity for the purposes of ihe Companies Act 2006. present their report with the
financial statements of the charity for the year ended 31 March 2024. The trustees have adopted the provisions of
Accounting and Reporting by Charilies.. Statement of Recommended Practice applicable to charities preparing their
a¢count5 in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)
(effective l January 2019).
OBJECTIVES AND ACTIVITIES
Objectlves ond aim5
l ) The relief of poverty, sickness and distress by providin8 su¢h scrvices and facilities a5 are n¢¢essary including food,
Clothing and medical supplies;
2) To advance cducalion by providing grants and such items, servi¢¢s and facilities as required particularly, but not
¢xcIu5ively, for the benefit of young people.
3) To advance the islamic religion in accordance with the shia school of thought by such means as the trustees in iheir
Absolute discretion detcnnine.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Covernlng doeument
The charity is controlled by its governing dooumenL a deed of trust. and constitutes a limited company, limited by
guarantee, as defined by the Companies Act 2006.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
07016271 (En8land and Wales)
Registered Charity number
1133643
Reglstered office
Unli 4 Boultbee Business Units
Nechells Place
Birmingham
West Midlands
B7 SAR
Trustees
M J Lsmail Trustee
L G Jaffer Trustee
M P Kurji Trustee
Company Secretiry
L G Jaffer
Independent Examlner
Brindleys Limited
2 Whecleys Road
Edgba5ton
Birmingham
West Midlands
B152LD
Page I

PHARMACO FOUNDATION LTD
Report of the Trustees
for the Year Ended 31 March 2024
Approved by order of the board of trustees on 19 September 2024 and signed on its behalf by:
M J Ismail . Trustee
Page 2

Independent Examiner's Report to the Trustees of
Ph2rm*co Foundation LTD
Independent examiner's report to the trustees of Ph4rmaco FoundA¢ion LTD ('the Company,)
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2024.
Responsibilities and b*$is of report
As the charity's Iruslees of the Company (and also its directors for ihe purposes of ¢ompany law) you are responsible for the
preparation of the accounts in accordance with the requirements ofthe Companies Act 2006 (Ihe 2006 Act,).
Having satisfied myself thal the accounts of the Company are not required lo be audiled under Part 16 of ihe 2006 Act and
are eligible for independent examinalion, I report in respect of my examination of your charity's accounts as carried out
under Section 145 of the Charili¢s Act 2011 ('the 201 l Act.). In carrying out my ¢xamination I have followed Ihc Directions
given by the Charity Commission under Section 145(5) (b) of the LOI l Act.
Indepcndent examlner's stAtement
I have complelcd my examination. I confirni that no matters have come to my attention in connection with the examination
giving me cause to believe..
accounting records were not kept in respect of the Company a5 required by Section 386 of ihe 2006 Ael. or
the accounts do not a¢¢ord with those records. or
the accounts do not comply with the accounting requirements of Seclion 396 of the 2006 Acl other than any
requirement that the ac¢ounts give a true and fair view which is not a matter considered as part of an independent
examination; or
the accounts have not been prepared in accordance with the methods and principles of the Statemcnt of
Recommended Practice for accounting and reportin8 by charities (appltcable to charities preparing their accounts in
accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other rnatters in connection with the examination to which attenlion should be
drawn in this report in order to enable a proper understsnding of the accounts to be rcached.
d Sumar FCA
Brindleys Limited
2 Wheeleys Road
Edgbaston
Birmingham
West Midlands
B15 2LD
19 Seplember 2024
Page 3

PHARMACO FOUNDATZON LTD
Statement of FinAncial Activities
ror the YeAr Ended 31 March 2024
2024
Total
funds
2023
Total
funds
Unrestricted
funds
Restri¢ied
funds
Notes
INCOME AND ENDOWMENfs FROM
Donations and legacies
30.193
30,193
37,999
Investment in¢ome
Other income
33,123
33,123
34.027
929
Total
EXPENDITURE ON
Ch#rit%ble ACtivltl¢s
Education activities
Food & clothing aclivities
Religious activities
Assilance - Poor & Needy
2,917
2.917
3,833
5,000
8,227
4,250
18,000
18,000
Other
14.859
Total
NET INCOME
27,540
27,540
41,525
RECOIYCILIATION OF FUNDS
1 otal funds brought forward
385,905
385,905
344,380
TOTAL FUNDS CARRIED FORWARD
413.445
413 44S
385 905
The notes forni part of these financial statements
Page 4

PHARMACO FOUNDA TION LTD
StAttment of FinAnci41 Position
31 M4rth 2024
2024
Total
fund5
2023
Total
funds
Unrestricted
funds
Restricted
funds
Notes
FIXED ASSETS
Tangible ass¢ts
258.894
2S8,894
260,994
CURRENT ASSETS
Debtors
Cash at bank
17.489
149,991
17,489
149,991
649
132 724
167,480
167.480
133,373
CREDITORS
Amounts falling due within one year
10
(12,929)
(12,929)
(8,462)
NET CURREwf ASSETS
154,551
154 551
124911
TOTAL ASSETS LESS CURRENT
LIABILITIES
413,445
413,445
385,905
NET ASSETS
413.445
413,445
385 905
FUNDS
Unrestricted funds..
General fund
413,445
385 905
TOTAL FUNDS
413,445
385,905
The charitable company is enlitled to exemption from audit under Section 477 of the Companies Act 2006 for the year
ended 31 Mar¢h 2024.
The members have not required ihe company to obtain an audit of its financial statemenis for the year ended 31 March 2024
in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
(a)
ensuring that the charitable company keeps accounting records that comply with Sections 386 8nd 387 of the
Companies Act 2006 and
preparing financial stalements which give a true and fair view of the state of affairs of the chariiable company as at
the end of each financial year and of its surplus or deficit for each financial year in accordance with the
requirements of Se¢tions 394 and 395 and which otherwise comply with the requirements of the Companies Act
2006 relating to financial statements, so far as applicable to ihe charitable Company.
(b)
The notes forni part of these financial statements
Page 5
continued...

PHARiVIACO FOUNDATION LTD
Statement of Financial Position - continued
31 Mareh 2024
These financial ststements have been prepared in accordance with the provisions applicable to charitable companies subje¢t
to the small companies ￿gime.
The financial statements were approved by the Board of Trustees and authorised ftlr issue on 19 September 2024 and were
signed on 115 behalf by..
M J Ismail Trustee
The notes forni part of the￿ financial statements
Page 6

PHARMACO FOUNDATION LTD
Notes lo the Finaneial Statements
for the Year Ended 31 M4rch 2024
ACCOUNTING POLICIES
Basis of preparing the finAnci41 statements
The finanrial slatemenls of the charitable company. which is a public benefit entity under FRS 102, have been
prepared in accordance with the Charities SORP (FRS 102) 'Accounlin8 and Reporting by Charities.. Slalement of
Recommended Practire applicable to charitics preparing their accounts in accordance with the Financial Reporting
Standard applicable in the UK and Republic of Ireland (FRS 102) (effective l January 2019),. Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and R¢public of Ireland, and the Companies
Act 2006. The financial stalements have been prepared under the historical cost convention.
Income
All in¢ome is recognised in the Statement of Financial Aclivilies once the charity has entitlemenl to the funds, it is
probable that the income will be received and the arnount can be measured reliably.
Expendltur¢
Liabilitie5 are recognised as ¢xpenditure a5 soon as there is a Icgal or constru¢live obligation commilting the charity
to that expenditure, il is probable that a transfer of economic benefits will be required in settlement and the amount
of the obligation can be measured reliably. Expenditure is a¢¢ounled for on an accruals basis And has been classified
under headings that a88regate all cost related to the category. Where costs cannot be directly attributed lo particular
headings they have been allocated lo activities on a basis consistent with Ihe use of resources.
Tangible fixed assets
Depreciation is provided at the following annual rates in ordcr to write off each asset over its estimated useful life.
Freehold property
Plan( and machinery
Not depreciated
IOO/o on cost
Taxgtlon
The charity is exempt from corporation tax on its charitable acliviiies.
Fund Aeeountlng
Unrestricted funds can be used in accordance with the charitable objectives ai the discretion of the trustees.
Restricted funds can only be used for particular reslricled purposes within the objects of the charity. Restrictions
arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial stalemenls.
INVESTMENT INCOME
2024
2023
Rents received
33.123
34,027
Page 7
continued...

PHARMACO FOUNDATION LTD
Notes to the Finaneial St*ttments - continued
for the Year End¢d 31 March 2024
CHARITABLE ACTIVITIES COSTS
Dire¢t
Costs
Education activities
Assitance - Poor & Needy
2,917
SUPPORT COSTS
Governance
costs
Other
Totals
Other resources expended
13,859
NET INCOMEI{EXPENDITURE)
Net incomel(expenditur¢) is staled after chargingl(¢rediting):
2024
2023
Depreciation - owned assels
TRUSTEES, REMUNERATION AND BENEFITS
There werc no trustees, remuneration or other benefits for the year ended 31 March 2024 nor for the year ended
31 March 2023.
Trustees, expenses
There were no trustees, expenses paid for the year ended 31 March 2024 nor for the year ended 31 March 2023.
COMPARATIVES FOR TIIE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
Restricted
funds
Total
funds
INCOME AND ENDOWMENTS FROM
Donations And legacies
37,999
37,999
Investment income
Oiher income
34,027
929
34.027
929
Total
EXPENDITURE ON
Charitable #ctiviti¢s
Education activities
Food & clothing activities
Religious activities
Assitance - Poor & Needy
3,833
5.000
8.227
4.250
3.833
5,000
8,227
4,250
Page 8
continued...

PHARMACO FOUNDATION LTD
Notes to the Financial Statements- continued
for Ihe Year Ended 31 MArch 2024
COMPARATIVES FOR THE STATEMENT OF FINANCIAL AcfiviTIES- ¢ontinued
Unrestricted
Restricted
funds
funds
Total
funds
Other
Total
NET IIYCOME
41,525
41,525
RECONCILIATION Ob FUIYDS
Total funds brought forward
344.380
344.380
TOTAL FUNDS CARRIED FORWARD
385.905
385 905
TANGIBLE FIXED ASSETS
Freehold
property
Plant and
machinery
Tolals
COST
At l April 2023 and 31 March 2024
258,894
279,894
DEPRECIATION
At l April 2023
Charge for year
18,900
2,100
18,900
At 31 March 2024
NET BOOK VALUE
At 31 March 2024
258 894
258,894
At 31 March 2023
258,894
260.994
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
Trade debtors
Prepayments
14.214
368
281
649
Page 9
continued...

PHARMACO FOUNDATION LTD
Notes to the Financial Statements - continued
for the Year Ended 31 M4rch 2024
io.
CREDITORS: AMOUNTS FALLING DUE WITIIIN ONE YEAR
2024
2023
Trade creditors
VAT
Other creditors
Accrued exp¢ns¢s
5,122
1,371
5,300
1,315
1.497
5.250
400
ii.
MOVEMENT IN FUNDS
Net
movement
in funds
At
31.3.24
At 1.4.23
Unrestricted (unds
General fund
385,905
27,540
413.445
TOTAL FUNDS
385 905
27,540
413 445
Net movement in funds, included in the above are as follows:
Incoming
resources
Resources
expended
Movement
in funds
Unrestricted funds
General fund
63,316
(35,776)
27,540
TOTAL FUNDS
63J16
35 776)
27,540
CompRra¢lves for movement in funds
Net
movement
in funds
At
31,3.23
Al 1.4.22
Unr¢strleted funds
General fund
344,380
41,525
385.905
TOTAL FUNDS
344 380
385 905
Page 10
ontinued...

PHARMACO FOUNDATION LTD
Not&s to the Financial Statements- tontinued
for the Year Ended 31 Mgrch 2024
ii.
MOVEMENT IN FUNDS- continutd
Comparative net movement in funds, included in the above are as follows:
Incoming
resources
Resourc¢s
expendcd
Movement
in funds
Unrestricted funds
General fLtnd
72,955
(31,430)
41,525
TOTAL FUNDS
31430)
A current year 12 months and prior year 12 months combined position is as follows..
Net
movement
in funds
At
31.3.24
At 1.4.22
Unrestrlcted funds
General fund
344,380
69,065
413,445
TOTAL FUNDS
344,380
413 445
A current year 12 months and prior year 12 months combined nel movement in funds, included in the above are as
follows,.
Incoming
resour¢es
Resource5
expended
Movement
in funds
Unrestricted fund8
General fund
136.271
(67,206)
69,065
TOTAL FUNDS
136 271
67,206)
Pagell
continued...

PHARMACO FOUNDATION LTD
Note5 to the FinaneiAI Ststtments - continued
for the Year Ended 31 Mareh 2024
12.
RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 Mar¢h 2024.
Page 12

PHARMACO FOUNDATION LTD
Detailed Statement of FAn#nci41 Activities
for the Year Ended 31 March 2024
2024
2023
INCOME AND ENDOWMENTS
Donations llnd legAcies
Donations
30,193
37,999
Investmen¢ ineome
Rents received
33,123
34,027
Other income
HMRC Gift Aid
929
Total ineoming resources
63,316
72,955
EXPENDITURE
Charitable Activities
Education activities
Food & clothing activities
Religious activities
Assislance-Poor & Needy
2,917
3,833
5,000
8,227
20,917
21,310
Support costs
Other
Rates, Insurance & Slcharges
Light and heat
Depreciation of tangible fixed assets
5,808
5,951
4,830
2,790
13,859
9,720
Governance costs
Accountancy fees
Legal & Professional fees
400
600
400
400
Total resources expended
Net income
41.525
This page does not forni part of the statutory financial statements
Page 13